3 Strategies To Manage Case Scope In ANDA Patent Litigation
Law360 (December 10, 2019, 4:25 PM EST) -- In September, the U.S. Court of Appeals for the Federal Circuit was again presented with an appeal born from the case management of a multipatent case in Finjan Inc. v. Juniper Networks Inc., where the district court forced the parties to choose which patents and claims to litigate.
In Hatch-Waxman Act litigation, abbreviated new drug applicants often spend considerable time and resources defending against many asserted patents and many more asserted patent claims. The asserted patents and patent claims often define the scope of a case.
This article presents three strategies for ANDA applicants to help manage the scope of a multiclaim...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!